If the average purchases of the 2018-2019 period are compared with that of 2020-2021, adjusted for the number of users in ASSE -which amounts to almost one and a half million in December 2021, being higher compared to the previous period-, the expense in this list was practically the same: more than $639 million in the average of 2018-2019 and more than $644 million in 2020-2021, at prices adjusted for the CPI and for the number of users.
From the state agency they maintain that no conclusions can be drawn based on the number of users, since the adjustment of benefits is not centralized. There are conventions ASSE to the interior of the country with private, where people access services and remark that “a greater number of users does not necessarily imply an increase in services”.
Where it hurts
The list “of the 32” to which the FA It contains medicines for the treatment of high blood pressure, diabetes, cholesterol, cardiovascular diseases, allergies and mental health.
It should be noted that of the four years evaluated – the last two of the FA in the government (2018 and 2019) and the first of the coalition (2021 and 2021) – the impact evaluation of the budget cut in the item that reached 37% in the last two years according to Federico Preve (neurologist) of the Magnolia Front groupwho made the request together with legislators from the MPP Y Renewing Force.
The professional’s concern began at the end of last year, with two patients who had severe crises and who could not access the necessary drugs, for which he stated “The medication does not always arrive. Health spending cannot be cut.”
slow information
anticipate and the senator Charles Carrera They took the request to the Justice, after a request that was not answered. Finally, after several instances, and according to the sentence of September 8 of the judge dart martinezthe requested information was provided.
The budget for medication was previously discussed in the Rendering of Accounts, where in Parliament asse rejected the estimates of FAarguing the lack of inclusion of the expenditure made for the management of the covid during the previous months. According to the manager, in 2020 there was an increase in drug spending of ASSE (not including covid) that did not reach 1% compared to the previous year and in 2021 this rose to 14.5%.
Head and heart
Among the drugs identified to the decline is the enalapril (8 million less), a medication for blood pressure. In contrast and on the rise, the Paracetamolwith 32% more , associated with the treatment of covid-19 symptoms during the pandemic, and the antidepressant sertraline18%, and the quetiapine (antipsychotic) with an increase of 6%. The latter is the one that was purchased the most within the list of mental health medications included in said list.
about the low ASSE accused a “replacement” by another drug (losartan) in addition to a “decrease” in outpatient visits for that drug. While the highest spending on mental health begins according to the body, due to a rise in demand.
According to the calculations of FA Based on the request, the consumption of Enalapril was higher in the period 2020-2021 compared to 2019, and the consumption of losartan was “negligible” compared to the former.
Source: Ambito
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.
